Article
68Ga-DOTATATE-PET imaging in spinal meningeoma – Case report
Search Medline for
Authors
Published: | May 13, 2014 |
---|
Outline
Text
Objective: Imaging with positron emission tomography and 68Ga-DOTA peptides is a promising method in intracranial meningiomas. Especially in recurrent meningioma discrimination between scar tissue and recurrent tumor tissue in MRI is often difficult. We report the first case of 68Ga-DOTATATE-PET/CT imaging in recurrent spinal meningioma.
Method: A 64-year-old Caucasian female patient was referred to our department with the second recurrence of thoracic meningothelial meningioma. In MRI imaging it remained unclear if the multiple enhancements seen represented scar tissue or vital tumor. We offered 68Ga-DOTATATE-PET/CT imaging in order to evaluate the best strategy.
Results: 68Ga-DOTATATE-PET/CT imaging revealed strong tracer uptake in parts of the lesions. The pattern did distinctly differ from MRI enhancement. Multiple biopsies were performed in the PET-positive and PET-negative regions. Histological results confirmed the prediction of 68Ga-DOTATATE-PET with vital tumor in PET-positive regions and scar tissue in PET-negative regions.
Conclusions: Differentiating scar tissue from tumor may be challenging in recurrent spinal meningioma with MRI alone. In the presented case 68Ga-DOTATATE-PET imaging was able to differentiate non-invasively between tumor and scar.